Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cancers
|
June 27, 2020
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
International Journal of Molecular Sciences
|
September 23, 2022
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
Davide Busato, Monica Mossenta, Michele Dal Bo, et al.
International Journal of Molecular Sciences
|
January 27, 2021
A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients
Luca Bedon, Michele Dal Bo, Monica Mossenta, et al.
Expert Review of Clinical Pharmacology
|
March 26, 2019
Novel immunotherapeutic approaches for hepatocellular carcinoma treatment
Davide Busato, Monica Mossenta, Lorena Baboci, et al.
Cancers
|
August 3, 2019
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
Monica Mossenta, Davide Busato, Lorena Baboci, et al.
Plos One
|
July 26, 2017
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection
Jose L Slon Campos, Monica Poggianella, Sara Marchese, et al.
Journal of Translational Medicine
|
November 29, 2023
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
Davide Busato, Sara Capolla, Paolo Durigutto, et al.
Nanomedicine (London, England)
|
January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma
Monica Mossenta, Monica Argenziano, Sara Capolla, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cancers
|
June 27, 2020
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
International Journal of Molecular Sciences
|
September 23, 2022
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
Davide Busato, Monica Mossenta, Michele Dal Bo, et al.
International Journal of Molecular Sciences
|
January 27, 2021
A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients
Luca Bedon, Michele Dal Bo, Monica Mossenta, et al.
Expert Review of Clinical Pharmacology
|
March 26, 2019
Novel immunotherapeutic approaches for hepatocellular carcinoma treatment
Davide Busato, Monica Mossenta, Lorena Baboci, et al.
Cancers
|
August 3, 2019
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
Monica Mossenta, Davide Busato, Lorena Baboci, et al.
Plos One
|
July 26, 2017
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection
Jose L Slon Campos, Monica Poggianella, Sara Marchese, et al.
Journal of Translational Medicine
|
November 29, 2023
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
Davide Busato, Sara Capolla, Paolo Durigutto, et al.
Nanomedicine (London, England)
|
January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma
Monica Mossenta, Monica Argenziano, Sara Capolla, et al.
Page
of 1